In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Neuroperfusion Inc.

Latest From Neuroperfusion Inc.

The Tantalizing Market for Stroke Devices

A potentially enormous market without therapeutic options is attracting a lot of new technology developesr and venture capital to stroke. But the opportunity for clot-busting approaches is limited and getting enough patients for clinical trials is tough. In a market full of unknowns, one thing is certain: the ultimate goal of any stroke therapy is to avoid neurological deficit.
Medical Device Platform Technologies

Following Compass' Lead

Corporate venture investment programs like Guidant's Compass walk a thin line between traditional business development and traditional venture capital investing. Compass' goal is to help Guidant find new technology early that could eventually help one of Guidant's core business groups but still earn a return on investment in the event the technology ultimately proves of no value to the corporation.
Medical Device Strategy

Going Gangbusters on Stroke

The field of acute ischemic stroke is highly promising but enormously risky and fraught with disappointment. With the exception of tPA, no one has ever demonstrated a pharmaco-mechanism which produces efficacy in the clinic. For now, the key to success for companies will be good efficacy and safety data. Start-ups will need partners, but even alliances with major pharmaceutical companies don’t represent a short-term validation of their efforts, since even big companies are stumbling in this field.
BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Medical Devices
  • Therapeutic Areas
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Neuroperfusion Inc.
  • Senior Management
  • David C Cornett, Pres. & CEO
  • Contact Info
  • Neuroperfusion Inc.
    Phone: (714) 453-0150
    5 Jenner
    Suite 150
    Irvine, CA 92718-3808
    USA
UsernamePublicRestriction

Register